ENDRA Life Sciences (NDRA) Operating Income (2016 - 2021)
Historic Operating Income for ENDRA Life Sciences (NDRA) over the last 6 years, with Q4 2021 value amounting to -$3.1 million.
- ENDRA Life Sciences' Operating Income fell 3625.0% to -$3.1 million in Q4 2021 from the same period last year, while for Dec 2021 it was -$11.5 million, marking a year-over-year increase of 3.14%. This contributed to the annual value of -$10.8 million for FY2024, which is 281.74% down from last year.
- As of Q4 2021, ENDRA Life Sciences' Operating Income stood at -$3.1 million, which was down 3625.0% from -$2.7 million recorded in Q3 2021.
- In the past 5 years, ENDRA Life Sciences' Operating Income registered a high of -$360697.0 during Q1 2017, and its lowest value of -$3.3 million during Q3 2020.
- For the 5-year period, ENDRA Life Sciences' Operating Income averaged around -$2.4 million, with its median value being -$2.6 million (2019).
- Per our database at Business Quant, ENDRA Life Sciences' Operating Income crashed by 68670.41% in 2018 and then soared by 2799.16% in 2020.
- Over the past 5 years, ENDRA Life Sciences' Operating Income (Quarter) stood at -$2.3 million in 2017, then grew by 12.79% to -$2.0 million in 2018, then tumbled by 56.31% to -$3.1 million in 2019, then grew by 27.99% to -$2.3 million in 2020, then crashed by 36.25% to -$3.1 million in 2021.
- Its last three reported values are -$3.1 million in Q4 2021, -$2.7 million for Q3 2021, and -$3.2 million during Q2 2021.